These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3215246)

  • 21. Mechanisms of sex-steroid accumulation in the aetiology of human breast carcinoma: the role of intracellular sex hormone binding globulin.
    Iqbal MJ; Valyani SH; Roberts JV
    Anticancer Res; 1988; 8(3):479-81. PubMed ID: 3389751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estramustine phosphate on free androgens. A comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer.
    Van Poppel H; Werbrouck PW; Baert L
    Acta Urol Belg; 1990; 58(4):89-95. PubMed ID: 2093302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of synthetic anabolic steroids to testosterone-estradiol binding globulin and to rat prostate cytosol.
    Bicíková M; Hampl R; Stárka L
    Endocrinol Exp; 1977; 11(2):85-90. PubMed ID: 301824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating steroid hormones and the risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis and metabolism of androgenic hormones in cancer of the prostate.
    Di Silverio F; Gagliardi V; Sorcini G; Sciarra F
    Invest Urol; 1976 Jan; 13(4):286-8. PubMed ID: 128534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
    J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basis for hormonal management of advanced prostate cancer.
    Geller J
    Cancer; 1993 Feb; 71(3 Suppl):1039-45. PubMed ID: 7679038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
    Lukkarinen O; Hammond GL; Kontturi M; Vihko R
    Invest Urol; 1980 Jan; 17(4):328-31. PubMed ID: 6444293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P
    Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy].
    Peyromaure M; Rebillard X; Ruffion A; Salomon L; Villers A; Soulie M;
    Prog Urol; 2008 Jan; 18(1):2-8. PubMed ID: 18342148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancer.
    Geller J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):28-35. PubMed ID: 3883502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.
    Rouleau M; Neveu B; Caron P; Morin F; Toren P; Lacombe L; Turcotte V; Lévesque É; Guillemette C; Pouliot F
    J Urol; 2022 Dec; 208(6):1214-1225. PubMed ID: 36102111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex steroid hormone metabolism and prostate cancer.
    Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer does not influence androgen levels: a radical prostatectomy cohort study.
    De Nunzio C; Carluccini A; Cicione A; Squillacciotti S; Trucchi A; Cantiani A; Leonardo C; Tubaro A
    Urol Int; 2011; 86(2):161-6. PubMed ID: 21252482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.
    Suzuki K; Nishiyama T; Hara N; Yamana K; Takahashi K; Labrie F
    Prostate Cancer Prostatic Dis; 2007; 10(3):301-6. PubMed ID: 17387321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of prostate growth.
    Coffey DS; Isaacs JT
    Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.